Resolve Medicolegal Limited - Accounts to registrar (filleted) - small 23.2.5
Resolve Medicolegal Limited - Accounts to registrar (filleted) - small 23.2.5
| REGISTERED NUMBER: |
| UNAUDITED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 30 SEPTEMBER 2023 |
| FOR |
| RESOLVE MEDICOLEGAL LIMITED |
| RESOLVE MEDICOLEGAL LIMITED (REGISTERED NUMBER: SC432222) |
| CONTENTS OF THE FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 30 SEPTEMBER 2023 |
| Page |
| Company Information | 1 |
| Balance Sheet | 2 |
| Notes to the Financial Statements | 4 |
| RESOLVE MEDICOLEGAL LIMITED |
| COMPANY INFORMATION |
| FOR THE YEAR ENDED 30 SEPTEMBER 2023 |
| DIRECTORS: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| RESOLVE MEDICOLEGAL LIMITED (REGISTERED NUMBER: SC432222) |
| BALANCE SHEET |
| 30 SEPTEMBER 2023 |
| 2023 | 2022 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Tangible assets | 4 |
| CURRENT ASSETS |
| Debtors | 5 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 6 |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| PROVISIONS FOR LIABILITIES |
| NET ASSETS |
| RESOLVE MEDICOLEGAL LIMITED (REGISTERED NUMBER: SC432222) |
| BALANCE SHEET - continued |
| 30 SEPTEMBER 2023 |
| 2023 | 2022 |
| Notes | £ | £ | £ | £ |
| CAPITAL AND RESERVES |
| Called up share capital | 7 |
| Retained earnings |
| SHAREHOLDERS' FUNDS |
| The directors acknowledge their responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| RESOLVE MEDICOLEGAL LIMITED (REGISTERED NUMBER: SC432222) |
| NOTES TO THE FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 30 SEPTEMBER 2023 |
| 1. | STATUTORY INFORMATION |
| Resolve Medicolegal Limited is a |
| 2. | ACCOUNTING POLICIES |
| BASIS OF PREPARING THE FINANCIAL STATEMENTS |
| RELATED PARTY EXEMPTION |
| The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group. |
| TURNOVER |
| The turnover shown in the profit and loss account represents amount earned during the year and is recognised when the company obtains the right to consideration. |
| TANGIBLE FIXED ASSETS |
| Improvements to property | - |
| Fixtures and fittings | - |
| All fixed assets are initially recorded at cost. |
| TAXATION |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
| RESOLVE MEDICOLEGAL LIMITED (REGISTERED NUMBER: SC432222) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 30 SEPTEMBER 2023 |
| 2. | ACCOUNTING POLICIES - continued |
| DEFERRED TAX |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS |
| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was |
| 4. | TANGIBLE FIXED ASSETS |
| Improvements | Fixtures |
| to | and |
| property | fittings | Totals |
| £ | £ | £ |
| COST |
| At 1 October 2022 |
| Additions |
| At 30 September 2023 |
| DEPRECIATION |
| At 1 October 2022 |
| Charge for year |
| At 30 September 2023 |
| NET BOOK VALUE |
| At 30 September 2023 |
| At 30 September 2022 |
| RESOLVE MEDICOLEGAL LIMITED (REGISTERED NUMBER: SC432222) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 30 SEPTEMBER 2023 |
| 5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2023 | 2022 |
| £ | £ |
| Trade debtors |
| Prepayments and accrued income |
| 6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2023 | 2022 |
| £ | £ |
| Tax |
| VAT | 89,118 | 37,221 |
| Accrued expenses |
| 7. | CALLED UP SHARE CAPITAL |
| Allotted, issued and fully paid: |
| Number: | Class: | Nominal | 2023 | 2022 |
| value: | £ | £ |
| Ordinary | £1 | 100 | 100 |
| 8. | RELATED PARTY DISCLOSURES |
| Throughout the year the company paid £18,000 (2022 - £18,000) to Broadbent Legal Services Limited, a company in which Mr Broadbent is a Director and Shareholder, for Management Consultancy. The balance owing as at the balance sheet date was £Nil (2022 - £Nil). |
| Throughout the year the company paid £6,000 (2022 - £6,000) to Simpsons Orthopaedics Limited, a company in which Mr Simpson is a Director and Shareholder, for Management Consultancy. The balance owing as at the balance sheet date was £Nil (2022 - £Nil) |
| Throughout the year the company paid £6,000 (2022 - £6,000) to Mr D Donaldson for Management Consultancy. The balance owing as at the balance sheet date was £Nil (2022 - £Nil) |
| Throughout the year the company paid £6,000 (2022 - £6,000) to Clayton Medical, a company in which Mr Clayton is a Director and Shareholder, for Management Consultancy. The balance owing as at the balance sheet date was £Nil (2022 - £Nil). |